Lupin
Stay updated with the latest news and articles about Lupin.
Latest Articles
Lupin gets FDA approval for key respiratory drug gSpiriva
Lupin Limited (Lupin), a global pharma major announced its approval from the United States Food and Drug Administration (U.S. FDA).
Stocks to watch: Wipro, DMart, HDFC Bank, Piramal Pharmacy, and more
Today's top stocks include HDFC Bank, Avenue Supermarts, Wipro, and many Pharma businesses.
Stocks to watch: NDTV, TCS, JK Cement, M&M, Kotak Mahindra Bank and more
Due to the fact that they have exceeded the 95% market-wide position limit, the NSE has added the following stocks to its list of prohibited securities under the F&O segment for Wednesday trading: Balrampur Chini, Bhel, Delta Corp, Gujarat Narmada Valley Fertilizers and Chemicals, Indiabulls Housing Finance, and Sun TV.
Stocks to watch: TCS, HCL Technologies, HDFC, Lupin, Allcargo Logistics and more
Stocks to keep an eye on today: Monday's trading will centre on shares of companies like TCS, Lupin, HDFC, IDBI Bank, Power Grid, and others.
Stocks to watch today: Lupin, Vodafone Idea, L&T Tech and others
Stocks to watch today: The trading session on Tuesday will centre on shares of companies including Vodafone Idea, Lupin, L&T Tech, and others.
Stocks to watch today: Tata Power, Maruti Suzuki, Mahindra Logistics, ONGC, Wipro
As RBL Bank exceeded the market-wide position limit by 95% on Thursday, it was added to the list of prohibited securities within the F&O segment. Due to the release of their June quarter results, Websol Energy System and Consolidated Construction Consortium will be in the spotlight.
What is net worth of Rakesh Jhunjhunwala? lets find out
Rakesh Jhunjhunwala, an investor with a Midas sense, is always referred to as India’s own Warren Buffet. He is a merchant and also a chartered accountant. According to Forbes' affluent List, Jhunjhunwala is the 48th richest individual in the nation. This is all about his net worth.
Market Closing: Sensex, Nifty close with gains; Pharma stocks outperform
The Indian indices closed higher after rallying at good figures with Nifty crossing 11330 and Sensex crossing above 38400 on Monday.
Q1 FY21 Results: Lupin posts 65% decline in net profits to Rs 106.90 crore
Drug firm Lupin has reported a 64.72 per cent decline in its consolidated net profit to Rs 106.90 crore for the quarter to April-June 2020.
Showing 87 of 87 articles